Home Cart Sign in  
Chemical Structure| 918431-92-2 Chemical Structure| 918431-92-2

Structure of 918431-92-2

Chemical Structure| 918431-92-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 918431-92-2 ]

CAS No. :918431-92-2
Formula : C11H19FN2O3
M.W : 246.28
SMILES Code : O=C(N1CCC(F)(C(N)=O)CC1)OC(C)(C)C
MDL No. :MFCD17677054

Safety of [ 918431-92-2 ]

Application In Synthesis of [ 918431-92-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 918431-92-2 ]

[ 918431-92-2 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 614731-04-3 ]
  • [ 918431-92-2 ]
YieldReaction ConditionsOperation in experiment
100% A solution of <strong>[614731-04-3]1-boc-4-fluoro-4-piperidinecarboxylic acid</strong> (300 mg, 1.15 mmol) in ethylene glycol dimethyl ether (15 mL) was treated with 4-methylmorpholine (0.13 mL, 1.15 mmol) and isopropyl chloroformate (1 M solution in toluene, 1.38 mL, 1.38 mmol) at -15C. After stirring for 10 mm, ammonia solution (0.5 M in dioxane, 3.50 mL, 1.75 mmol) was added.The reaction mixture was stirred at RT for 18h. The solvents were evaporated under reduced pressure, the crude product was dissolved in EtOAc, washed with 1 N NaOH solution, water and brine and the organic layers were dried over sodium sulfate, filtered and evaporated to dryness to get 185 mg (65 %) of a white powder. The product was used for the next step without further purification. LCIMS (Method A): Rt = 1.79 mm,(M+H) 173.
90% With ammonium chloride; N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; at 25℃; tert-Butyl 4-carbamoyl-4-fluoropiperidine-1-carboxylate (0414) In a 250-mL round-bottom flask were combined <strong>[614731-04-3]1-[(tert-butoxy)carbonyl]-4-fluoropiperidine-4-carboxylic acid</strong> (3 g, 12.13 mmol, 1.00 equiv), DMF (50 mL), NH4Cl (1.75 g, 32.72 mmol, 1.50 equiv), HATU (9.23 g, 24.27 mmol, 2.00 equiv), and iPr2NEt (3.13 g, 24.22 mmol, 2.00 equiv). The resulting solution was stirred overnight at 25 C. The resulting solution was extracted with 200 mL of EtOAc and the organic layers were combined, washed with 5×50 mL of H2O, then applied onto a silica gel column with ethyl acetate/petroleum ether, affording 2.7 g (90%) of the product as a white solid.
 

Historical Records

Technical Information

Categories